Compensatory mechanisms degenerative neurologic diseases Insights parkinsonism animal models parkinsonism ability substantial proportion dopaminergic neurons behavioral deficits systems function dopaminergic pathway nigrostriatal projection increases rate synthesis release dopamine compensatory adjustments capacity fivefold rise dopamine delivery neuron enhancement receptor up-regulation reuptake due loss nerve endings augmented occupancy dopamine receptors constitute compensatory mechanism humans positron emission tomography subclinical impairment dopaminergic nigrostriatal pathway subjects risk parkinsonism Lytico-Bodig amyotrophic lateral sclerosis-parkinsonism dementia complex Guam separation patients overt idiopathic parkinsonism controls vivo positron emission tomography postmortem analysis neurochemical assay disparity attributable reduction number nigrostriatal nerve endings vivo relative increase extracellular dopamine active reuptake nerve endings important mechanism dopamine synaptic cleft contrast postmortem setting dopamine storage vesicles nerve endings available biochemical degradation interval death brain analysis possible differences part dissimilar kinetic systems exogenous endogenous levodopa 